These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26886286)
21. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis. Ueda M; Hung YC; Terai Y; Saito J; Nunobiki O; Noda S; Ueki M Gynecol Oncol; 2005 Mar; 96(3):736-40. PubMed ID: 15721419 [TBL] [Abstract][Full Text] [Related]
22. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer. Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667 [TBL] [Abstract][Full Text] [Related]
23. An interleukin-10 gene polymorphism associated with the development of cervical lesions in women infected with Human Papillomavirus and using oral contraceptives. Chagas BS; Gurgel AP; da Cruz HL; Amaral CM; Cardoso MV; Silva Neto Jda C; da Silva LA; de Albuquerque EM; Muniz MT; de Freitas AC Infect Genet Evol; 2013 Oct; 19():32-7. PubMed ID: 23800422 [TBL] [Abstract][Full Text] [Related]
24. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036 [TBL] [Abstract][Full Text] [Related]
25. Association of CDKN2A polymorphisms with the severity of cervical neoplasia in a Brazilian population. Vargas-Torres SL; Portari EA; Klumb EM; Guillobel HC; de Camargo MJ; Russomano FB; Macedo JM Biomarkers; 2014 Mar; 19(2):121-7. PubMed ID: 24491138 [TBL] [Abstract][Full Text] [Related]
26. Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression. Chuery ACS; Silva IDCGD; Ribalta JCL; Speck NMG Braz J Infect Dis; 2017; 21(3):248-254. PubMed ID: 28347732 [TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of the relationship between p21 Ser31Arg polymorphism and cervical cancer. Ma Y; Zhang Y; Lin L; Guo X; Wu Y; Wen W; Li F; Liu P Tumour Biol; 2013 Dec; 34(6):3887-92. PubMed ID: 23832542 [TBL] [Abstract][Full Text] [Related]
28. Role of p53 and p21 polymorphisms in the risk of cervical cancer among Chinese women. Jiang P; Liu J; Li W; Zeng X; Tang J Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):671-6. PubMed ID: 20732856 [TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer. Lai ZZ; Ni-Zhang ; Pan XL; Song L J Int Med Res; 2013 Aug; 41(4):1027-36. PubMed ID: 23816930 [TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208 [TBL] [Abstract][Full Text] [Related]
31. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. Hong D; Ye F; Chen H; Lü W; Cheng Q; Hu Y; Xie X Int J Gynecol Cancer; 2008; 18(1):104-9. PubMed ID: 17466048 [TBL] [Abstract][Full Text] [Related]
32. Association between interluekin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population. Cong J; Liu R; Wang X; Sheng L; Jiang H; Wang W; Zhang Y; Yang S; Li C Int J Clin Exp Pathol; 2015; 8(8):9567-73. PubMed ID: 26464720 [TBL] [Abstract][Full Text] [Related]
33. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women. González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455 [TBL] [Abstract][Full Text] [Related]
34. Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis. Ueda M; Hung YC; Terai Y; Yamaguchi H; Saito J; Nunobiki O; Noda S; Ueki M Gynecol Oncol; 2005 Jul; 98(1):129-33. PubMed ID: 15894356 [TBL] [Abstract][Full Text] [Related]
35. IFN-gamma and IL-12B polymorphisms in women with cervical intraepithellial neoplasia caused by human papillomavirus. do Carmo Vasconcelos de Carvalho V; de Macêdo JL; de Lima CA; da Conceição Gomes de Lima M; de Andrade Heráclio S; Amorim M; de Mascena Diniz Maia M; Porto AL; de Souza PR Mol Biol Rep; 2012 Jul; 39(7):7627-34. PubMed ID: 22327783 [TBL] [Abstract][Full Text] [Related]
37. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis. Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140 [TBL] [Abstract][Full Text] [Related]
38. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Chen J; Amos CI; Merriman KW; Wei Q; Sen S; Killary AM; Frazier ML Pancreas; 2010 Jan; 39(1):1-4. PubMed ID: 19910837 [TBL] [Abstract][Full Text] [Related]
39. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430 [TBL] [Abstract][Full Text] [Related]
40. Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study. Liu F; Wei YG; Luo LM; Wang WT; Yan LN; Wen TF; Xu MQ; Yang JY; Li B Int J Cancer; 2013 May; 132(9):2056-64. PubMed ID: 23034899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]